#EMPHASISHF - Twitter Hashtag

about 5 years ago

@hswapnil @Ricky_Turgeon @ChristosArgyrop @Nephro_Sparks @SanjayGill1 @scoca1 @NephroGuy @Sglt2inhibitorL @askrenal @edgarvlermamd @VelezNephHepato @nephondemand @aishaikh @Jwaitz @MarkCanney FYI @hswapnil Mean eplerenone dose achieved in #ARTSHF = 39mg Mean eplerenone dose achieved in #EMPHASISHF = 39mg So finerenone in #ARTSHF was compared head to head against eplerenone at a dose proven to reduce mortality in mild HFrEF.

1

0

DrPatWJyg @w_jyg

almost 6 years ago

IMHO, it’s one of the most under prescribed antiHF with Great Data!!! #EMPHASISHF RR24% ⬇️in CVDeath & 42% ⬇️HFH #RALES RR30%⬇️ All cause mortality (HF death & SCD）

SABOURETCardiologist @SABOURETCardio

almost 6 years ago

#MRA are under prescribed especially in #HF. Even it’s sometimes complex to titrate in frailty patients, it’s worth to try. #cardiotwitter

SABOURETCardio's tweet photo. #MRA are under prescribed especially in #HF. Even it’s sometimes complex to titrate in frailty patients, it’s worth to try. #cardiotwitter https://t.co/O6MCHQfT1t

4

57

11

4

0

1

4

1

0

Muthu Vaduganathan @mvaduganathan

over 6 years ago

How do you communicate the expected lifetime benefits of HF therapies? New data in @TheLancet from 3 RCTs (#EMPHASISHF #PARADIGMHF #DAPAHF) estimate up to *6 years* of survival gains. Combination ARNI+BB+MRA+SGLT2i = new therapeutic standard in HFrEF. 📎https://t.co/xd23cW9Ovp

mvaduganathan's tweet photo. How do you communicate the expected lifetime benefits of HF therapies?

New data in @TheLancet from 3 RCTs (#EMPHASISHF #PARADIGMHF #DAPAHF) estimate up to *6 years* of survival gains.

Combination ARNI+BB+MRA+SGLT2i = new therapeutic standard in HFrEF.

📎https://t.co/xd23cW9Ovp https://t.co/aDibWTgjrt

24

362

180

42

0

Top Tweets for #EMPHASISHF

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users